News about Manufacturing

Upperton Completes 15M GMP Manufacturing Facility

Upperton Completes £15M GMP Manufacturing Facility<br />

Manufacturing | 14/07/2023 | By Sudeep Soparkar |  777

Pharma giant GSK to build Singapore facility making Hepatitis B vaccine

Pharma giant GSK to build Singapore facility making Hepatitis B vaccine

Manufacturing | 14/07/2023 | By Sudeep Soparkar |  1030

Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility

Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility

Manufacturing | 13/07/2023 | By Sudeep Soparkar |  956

One-Stop Facility with cGMP Manufacturing to Bolster AMEAs Biopharma Industry

One-Stop Facility with cGMP Manufacturing to Bolster AMEA’s Biopharma Industry

Manufacturing | 13/07/2023 | By Sudeep Soparkar |  932

LIFERA, SANOFI and ARABIO Sign MOU to Manufacture and Supply Vaccines in Saudi Arabia

LIFERA, SANOFI and ARABIO Sign MOU to Manufacture and Supply Vaccines in Saudi Arabia, Boosting Local Production with a New State-Of-The-Art Manufacturing Facility

Manufacturing | 06/07/2023 | By Sudeep Soparkar |  1038

Aurigene Pharma to set up facility with $40 million in Genome Valley

Aurigene Pharma to set up facility with $40 million in Genome Valley

Manufacturing | 06/07/2023 | By Sudeep Soparkar |  1100

Tower Cold Chain Expands Presence with Opening of American Centre of Excellence

Pharmaceutical thermal protection specialist Tower Cold Chain has opened its new headquarters in the Americas region.<br />

Manufacturing | 06/07/2023 | By Sudeep Soparkar |  613

Aurobindo Pharma arm in Puerto Rico to halt production for expansion works

Aurobindo Pharma’s wholly owned step-down subsidiary in Puerto Rico, Auro PR Inc., will halt manufacturing to facilitate a restructuring of its facility from next month.

Manufacturing | 06/07/2023 | By Sudeep Soparkar |  1200

Shine Opens Largest Lu-177 Production Facility in North America

Shine Opens Largest Lu-177 Production Facility in North America

Manufacturing | 27/06/2023 | By Sudeep Soparkar |  1320

Boehringer Ingelheim breaks ground on 285M API plant in Germany

Boehringer Ingelheim kicked off construction on a new 285 million euro ($315 million) plant at its German headquarters that will produce active pharmaceutical ingredients and drugs for clinical trials.

Manufacturing | 15/06/2023 | By Sudeep Soparkar |  1173